· AIM:Toinvestigatetheserumlevelsofvascular endothelialgrowthfactorreceptor-2 (VEGFR-2)and adropininage-relatedmaculardegeneration(AMD) patients. ·
.ThemostcommonformofNV inAMDisCNV,inwhichvesselsgrowfromthechoroid intothesubretinalspaceorretina.VEGF-Aisamajorfactor inthedevelopmentofCNV [2] .Ithastwomainreceptors, whicharereceptortyrosinekinases,designatedvascular endothelialgrowthfactorreceptor-1(VEGFR-1)andvascular endothelialgrowthfactorreceptor-2(VEGFR-2).VEGFR-2 isknownasthemajorangiogenicreceptorforVEGF-Aon endothelialcells [3] .Inaddition,protectivefunctionsare mediatedbyVEGFR-2,asareautoregulatoryfunctionsof VEGF-Aexpression [4] [5] .VEGFR-1regulatesVEGFactivityin thevascularendotheliumbypreventingbindingofVEGFto VEGFR-2 [6] . Amongtheangiogenicfactors,VEGFisthemostimportant contributortotheangiogenesisinAMDpatients;however, thereislimitedevidenceabouttheroleofanti-angiogenic moleculesinAMD [7] [8] .Recently,Uehara [9] found decreasedserumVEGFR-1levelsinwettypeAMD comparedtodrytypeandSharma [10] reportedan associationbetweentheserumlevelsofVEGFR-2andwet typeAMD. Adropinwasfoundin2008asasecretedproteininvolvedin energyhomeostasis,metabolicadaptationtomacronutrients andmodulationofinsulinsensitivityanddiabetes [11] .Lovren 陨灶贼允韵责澡贼澡葬造皂燥造熏灾燥造援 9熏晕燥援 4熏 Apr.18, 圆园16 www.ijo.cn 栽藻造押8629原愿圆圆源缘员苑圆 8629-82210956 耘皂葬蚤造押ijopress 岳员远猿援糟燥皂 [12] reportedthatadropinmayalsohavenon-metabolic propertiesincludingtheregulationofendothelialfunction. Adropinwasexpressedinendothelialcellsandimproved angiogenesis-related responses.Authorsconcludedthat adropinpotentlyupregulatesVEGFR-2inendothelialcells andthatgenesilencingofVEGFR-2significantlyimpaires theeffectsadropinhadonmodulatingendothelialcell survivalandfunction [12] . [13] .In wettypeAMD,amajorfactorinNVwhichmayexertfrom theretinaorfromthechoroidistheVEGF.Itispresentina solubleandboundformandinteractswithtworeceptors, VEGFR-1andVEGFR-2,topromoteangiogenesisand vascularintegrity. Endothelialcellsproduceseveralfactorsthatregulatecellular adhesion,thromboresistance,smoothmuscleproliferation and vesselwallinflammation.Therefore,endothelial dysfunctionisassociatedwithseveralpathophysiological conditions,including atherosclerosis,hypertensionand diabetes [14] .Recentstudiessupportedtheemergingconceptof endothelialdysfunctioninthecourseofAMD.Clinicaltrials havefoundalinkbetweenendothelialdysfunctionand drusenformationorNVinAMDpatients [15] .Theprotective roleofadropinontheendotheliumhasbeenshown previously [11, [15] [16] [17] .Inthisstudy,weinvestigatedwhetherthe serumlevelsofVEGFR-2andadropinarerelatedtothe developmentofAMD. WeobservedlowerconcentrationsofserumVEGFR-2in patientswithAMD,particularlyinthewettype.Serumlevel ofadropinwasfoundtobelessimportantinthepathogenesis ofAMD.VEGFR2isthemajorpositivesignaltransducerfor both physiologicalandpathologicalangiogenesis.The loweringofcirculatingVEGFR-2levelsmaybeexplainedby ahigherbindingoftheVEGFtoitsR2receptorstoform VEGF-receptorcomplexes.SolubleisoformsofVEGFR-1 and-2aredetectedinbloodcirculation.Thesereceptorsare abletobindtheirligands,therebycontrollingtheir biodisponibilityandinhibitingtumororischemia-induced angiogenesis [18] [19] [20] [21] [22] [23] .Generally,circulatingreceptorsinactivate theirligandsbybindingwiththem,sincethesolublereceptor doesnotpossesstheintracellulardomainrequiredtoinitiate signaling [24] .Both and studieshaveshownthat elevatedlevelsofVEGFR-2hasanti-angiogenicactivity [25] [26] . [28] [29] [30] [31] .Lip [7] foundincreasedplasmaVEGFlevelsinAMDpatients comparedwithage-matchedcontrols.Interestingly,same authorsdidnotfindanysignificantdifferencebetweendry andwetAMDcaseswhencomparedVEGFvalues.Ina recentstudy,Tsai [8] foundincreasedplasmaVEGF levelsinAMDpatientscomparedwithcontrols.Theyfound significantlyhigherplasmaVEGFlevelsinwettypeAMD comparedwithdrytypeAMD.Morerecentstudieshave reportedelevatedserumVEGFR-2andreducedserum VEGFR-1inpatientswithneovascularAMD [9] [10] .Serumlevel ofadropinhasnotbeenstudiedinAMDpatientsyet. AnotherissueistherelationofserumlevelofVEGFR-2and adropintothediseaseseverity.SydorovaandLee [32] measuredhighlevelsofVEGFintheserumandvitreousof proliferativediabeticretinopathyandfoundserumVEGF levelswerehigheronlyinadvancedcases(proliferative vitreoretinopathy).Asshown,therearestillcontroversies regardingthebehaviouroftheserologicalbiomarkersin AMD.Surely,aneffectivebiomarkershouldbesimpleto analyzeandclinicallyrelevant.Unfortunately,manyofthe candidatemarkershaveyettobestandardized.Maybe sooner,thesebiomarkerswillbeimportanttoolsforAMD researchesbyprovidingascaleforevaluatingdisease progression.
Insummary,thedecreasedserumVEGFR-2levelseemsto berelatedtothedevelopmentofAMD.Futureresearches shouldstudywhetherdecreasingserumVEGFR-2level promotetheonsetofwettypeAMDandhowVEGFR-2 levelsdecreaseinthesepatients.Althoughadropindoesnot seemtoplayaroleinthepathophysiologyofAMD,itshould befurtherstudiedatmolecularlevelsinAMDpatients.As futurestudiescontinuetounravelthemolecularbiologyof AMD,bothourunderstandingaboutthisdebilitatingdisease andthetreatmentapproacheswillimprove.
